CN118556055A - 蛋白酪氨酸磷酸酶抑制剂及其使用方法 - Google Patents
蛋白酪氨酸磷酸酶抑制剂及其使用方法 Download PDFInfo
- Publication number
- CN118556055A CN118556055A CN202280088452.2A CN202280088452A CN118556055A CN 118556055 A CN118556055 A CN 118556055A CN 202280088452 A CN202280088452 A CN 202280088452A CN 118556055 A CN118556055 A CN 118556055A
- Authority
- CN
- China
- Prior art keywords
- hydroxy
- fluoro
- dihydro
- benzothiopyran
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163278336P | 2021-11-11 | 2021-11-11 | |
| US63/278336 | 2021-11-11 | ||
| PCT/US2022/049581 WO2023086495A1 (en) | 2021-11-11 | 2022-11-10 | Protein tyrosine phosphatase inhibitors and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN118556055A true CN118556055A (zh) | 2024-08-27 |
Family
ID=84887566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202280088452.2A Pending CN118556055A (zh) | 2021-11-11 | 2022-11-10 | 蛋白酪氨酸磷酸酶抑制剂及其使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250042894A1 (https=) |
| EP (1) | EP4430039A1 (https=) |
| JP (1) | JP2024543451A (https=) |
| CN (1) | CN118556055A (https=) |
| AU (1) | AU2022386164A1 (https=) |
| CA (1) | CA3236853A1 (https=) |
| MX (1) | MX2024005656A (https=) |
| WO (1) | WO2023086495A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20252789A1 (es) | 2023-05-24 | 2025-12-22 | Kumquat Biosciences Inc | Compuestos heterociclicos y usos de estos |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA94921C2 (en) * | 2005-12-08 | 2011-06-25 | Новартис Аг | 1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors |
| BR112020026086A2 (pt) * | 2018-06-21 | 2021-03-23 | Calico Life Sciences Llc | inibidores da proteína tirosina fosfatase e métodos de uso destes |
| IL286373B2 (en) * | 2019-03-14 | 2026-03-01 | Calico Life Sciences Llc | Protein tyrosine phosphate inhibitor compounds and uses thereof |
| CA3162069A1 (en) * | 2019-12-18 | 2021-06-24 | Elliot P. Farney | Protein tyrosine phosphatase inhibitors and methods of use thereof |
-
2022
- 2022-11-10 MX MX2024005656A patent/MX2024005656A/es unknown
- 2022-11-10 WO PCT/US2022/049581 patent/WO2023086495A1/en not_active Ceased
- 2022-11-10 JP JP2024527749A patent/JP2024543451A/ja active Pending
- 2022-11-10 US US18/709,204 patent/US20250042894A1/en active Pending
- 2022-11-10 AU AU2022386164A patent/AU2022386164A1/en active Pending
- 2022-11-10 EP EP22839527.3A patent/EP4430039A1/en active Pending
- 2022-11-10 CA CA3236853A patent/CA3236853A1/en active Pending
- 2022-11-10 CN CN202280088452.2A patent/CN118556055A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20250042894A1 (en) | 2025-02-06 |
| AU2022386164A1 (en) | 2024-05-23 |
| MX2024005656A (es) | 2024-08-06 |
| CA3236853A1 (en) | 2023-05-19 |
| EP4430039A1 (en) | 2024-09-18 |
| WO2023086495A1 (en) | 2023-05-19 |
| JP2024543451A (ja) | 2024-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3728238B1 (en) | Sulphonyl urea derivatives as nlrp3 inflammasome modulators | |
| JP6256772B2 (ja) | ヒストンデメチラーゼ阻害剤 | |
| JP2022106844A (ja) | Ｊａｋファミリーのキナーゼの阻害剤としてのイミダゾピロロピリジン | |
| CN114173803A (zh) | 氨基酸化合物的剂型和方案 | |
| JP2026509001A (ja) | Ｅ．ｇ．癌を治療するためのｒａｓ－ｐｉ３ｋモジュレーターとしての１－（（［１，１’，－ビフェニル］－２－イル）スルホニル）－４－フルオロ－ｎ－（３－（メチルスルホニル）アリル）ピペリジン－４－カルボキサミド誘導体 | |
| AU2015339196A1 (en) | Substituted tetrahydropyrans and method of use | |
| JP2008208129A (ja) | Ｐｐａｒアゴニスト活性を有する誘導体 | |
| AU2009205070A1 (en) | Phenyl acetamide derivative | |
| WO2021161105A1 (en) | P2x3 modulators | |
| CN120303272A (zh) | Nlrp3的抑制剂 | |
| EP3400226A1 (en) | Derivatives of pyrroloimidazole or analogues thereof which are useful for the treatment of inter alia cancer | |
| CN118525016A (zh) | 蛋白酪氨酸磷酸酶抑制剂及其使用方法 | |
| CN118556055A (zh) | 蛋白酪氨酸磷酸酶抑制剂及其使用方法 | |
| JPWO2011043381A1 (ja) | ピラゾロチアゾール化合物 | |
| WO2022092141A1 (ja) | 抗ウイルス活性を有するアミド誘導体 | |
| CN105358551A (zh) | Ccr2的八氢环戊并吡咯基拮抗剂 | |
| AU2017226674A1 (en) | 5-methyl-6-phenyl-4,5-dihydro-2h-pyridazin-3-one derivative | |
| JP3999861B2 (ja) | 新規ピリダジン誘導体及びこれを有効成分とする医薬 | |
| RU2836730C1 (ru) | Амидное производное, имеющее противовирусную активность | |
| WO2025237404A1 (zh) | 一种mc4r拮抗剂的多晶型物及其制备方法和应用 | |
| WO2024152995A1 (zh) | 一种大环类细胞周期蛋白抑制剂及其制备方法和应用 | |
| WO2026002203A1 (zh) | 组织蛋白酶c抑制剂化合物及其应用 | |
| HK40070149A (en) | Dosage forms and regimens for amino acid compounds | |
| HK40039990B (en) | Sulphonyl urea derivatives as nlrp3 inflammasome modulators | |
| HK40039990A (en) | Sulphonyl urea derivatives as nlrp3 inflammasome modulators |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |